Compare · LRCX vs QSI
LRCX vs QSI
Side-by-side comparison of Lam Research Corporation (LRCX) and Quantum-Si Incorporated (QSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- LRCX operates in Technology, while QSI operates in Industrials - the two are in different parts of the market.
- LRCX is the larger of the two at $321.05B, about 1548.5x QSI ($207.3M).
- Over the past year, LRCX is up 244.7% and QSI is down 23.5% - LRCX leads by 268.1 points.
- QSI has been more active in the news (12 items in the past 4 weeks vs 4 for LRCX).
- LRCX has more recent analyst coverage (25 ratings vs 4 for QSI).
- Company
- Lam Research Corporation
- Quantum-Si Incorporated
- Price
- -
- -
- Market cap
- $321.05B
- $207.3M
- 1M return
- +15.65%
- +28.14%
- 1Y return
- +244.67%
- -23.46%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- 2020
- News (4w)
- 4
- 12
- Recent ratings
- 25
- 4
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Quantum-Si Incorporated
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.
Latest LRCX
- Chief Legal Officer Harter Ava sold $1,554,547 worth of shares (6,010 units at $258.66) and exercised 6,010 shares at a strike of $77.04 (SEC Form 4)
- SEC Form 10-Q filed by Lam Research Corporation
- Lam Research Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Lam Research Corporation Reports Financial Results for the Quarter Ended March 29, 2026
- Lam Research downgraded by Erste Group
- Lam Research downgraded by Erste Group
- Lam Research Corporation Announces March Quarter Financial Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Lam Research Corporation
- Ethisphere Recognizes Lam Research as One of the World's Most Ethical Companies® for Fourth Consecutive Year
- Director Talwalkar Abhijit Y gifted 4,571 shares, decreasing direct ownership by 4% to 105,424 units (SEC Form 4)
Latest QSI
- Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
- Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
- SEC Form 4 filed by Keyes Jeffry R.
- SEC Form 4 filed by Hawkins Jeffrey Alan
- SEC Form 144 filed by Quantum-Si Incorporated
- SEC Form 144 filed by Quantum-Si Incorporated
- Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
- Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
- Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)